AbbVie Wins First Round in Humira Antitrust Lawsuit
The purpose of the secondary patent filings was to assemble a thicket of patents, 132 in all, to prohibit competition from biosimilar companies.
Intellectual Property
-
Read more: AbbVie Wins First Round in Humira Antitrust Lawsuit -
Read more: How are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process? How are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process?
Pharmaceutical companies are now also engaging the public themselves in an attempt to build trust in their products.
-
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants Clash of Titans? A Brewing Dispute between Telehealth Giants
Competition between telehealth providers spilled into open conflict last month, as incumbent Teladoc filed a patent infringement suit against Amwell.
-
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
-
Read more: How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development? How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development?
Moderna’s vaccine works using a completely novel mechanism, unlike any other vaccine currently approved anywhere in the world.
-
Read more: COVID-19 Vaccine Advance Purchases Explained COVID-19 Vaccine Advance Purchases Explained
No vaccine for the novel coronavirus has been approved. Nevertheless, governments and organizations are making deals for tens of millions of doses.
-
Read more: What Ever Happened to NIH’s “Fair Pricing” Clause? What Ever Happened to NIH’s “Fair Pricing” Clause?
It remains to be seen whether Congress or the Administration adopt more decisive measures toward the control of drug prices than they have in the past.
-
Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition To Cut Prescription Drug Spending, Stop Delays for Generic Competition
While generic competition is crucial for reducing drug prices, brand-name drug manufacturers can utilize several strategies to delay such competition.
-
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
What if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable?
